1AD
Click for more information
7.41% 2.5¢ adalta limited

Biotech Ripper to Accumulate

  1. MandB
    2,092 Posts.
    lightbulb Created with Sketch. 103
    clock Created with Sketch.
    17/07/19
    05:25
    Post #: 39552690
    So path to human trials is relatively short.

    Four week toxicology study. Results due between now and Dec. These may come early

    Human Trials
    Phase 1 study to commence early Jan. Really very short time frame in biotech terms.

    Strong management team

    Really good chance to accumulate under 25 cents.

    Been stalking this for a couple of years.

    Giddy up!






    1AD Price at posting: 16.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

I88 Infini flags evidence of uranium on-site Portland Creek project to wrap up maiden run
right-arrow Created with Sketch.
NEWS The Telstra twist - What the job cuts decision mean for investors?
right-arrow Created with Sketch.
ARU More, more, more: Arafura eyes another US$300M in funding for flagship
right-arrow Created with Sketch.
SS1 Sun Silver books specialty firm to enhance US solar panel silver paste grant
right-arrow Created with Sketch.
SLS Historical prospects impress Solstice, with 25% copper and significant anomaly
right-arrow Created with Sketch.
YRL Yandal lines up prime gold targets at Ironstone Well-Barwidgee
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢ 		Change
-0.002(7.41%) 		Mkt cap ! $13.33M
Open High Low Value Volume
2.7¢ 2.7¢ 2.5¢ $5.826K 219.8K

Buyers (Bids)

No. Vol. Price($)
2 664357 2.4¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 196034 2
View Market Depth
Last trade - 13.07pm 28/05/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.